Arovella Therapeutics Ltd (ALA)

Sydney

Currency in AUD

0.061

0.000(0.00%)

Closed·28/08

Fair Value

Unlock Value

Day's Range

0.058

0.062

52 wk Range

0.058

0.125

ALA Income Statement

Assess the Arovella Therapeutics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ALA net worth.

Period Ending:

2017

30/06

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

0.3

1.45

1.95

3.44

3.5

Total Revenues Growth

aa.aa

-70.11%

+391.76%

+34.2%

+76.22%

+1.69%

Cost Of Revenues

aa.aa

0.21

0.2

Gross Profit

aa.aa

0.09

1.25

1.95

3.44

3.5

Gross Profit Growth

aa.aa

-88.09%

+1,309.67%

+56.03%

+76.22%

+1.69%

Gross Profit Margin %

aa.aa

30%

86.01%

100%

Other Operating Expenses, Total

aa.aa

7.69

9.88

10.83

11.34

11.21

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+63.49%	+28.6%	+9.56%	+4.71%	-1.1%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.6	3.98	6.74	6.52	5.87
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.9	2.37	2.41	3.06	3.27
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.63	2.7	1.64	1.65	1.96

Operating Income

aa.aa

-7.6

-8.63

-8.88

-7.9

-7.72

Operating Income Growth

aa.aa

-92.05%

-13.63%

-2.83%

+11.01%

+2.31%

EBIT Margin %

aa.aa

-2,568.01%

-593.4%

-454.69%

-229.61%

-220.59%

Net Interest Expenses

aa.aa

-0.19

0.03

0.13

0.39

0.8

Net Interest Expenses Growth

aa.aa

-887.3%

+113.25%

+414.55%

+199.4%

+105.38%

Interest Expense, Total

aa.aa

-0.19

-0

-0.01

Interest And Investment Income

aa.aa

0.03

0.14

0.39

0.8

Other Non Operating Expenses, Total

aa.aa

-0

-0.02

EBT, Excl. Unusual Items

aa.aa

-7.79

-8.62

-8.75

-7.51

-6.92

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-0.83

-1.56

EBT, Incl. Unusual Items

aa.aa

-8.62

-10.18

-8.75

-7.51

-6.92

EBT, Incl. Unusual Items Growth

aa.aa

-70.79%

-18.11%

+14.1%

+14.14%

+7.89%

EBT, Incl. Unusual Items Margin

aa.aa

-2,914.23%

-699.91%

-448.03%

-218.28%

-197.72%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-8.62

-10.18

-8.75

-7.51

-6.92

Minority Interest

aa.aa

Net Income

aa.aa

-8.62

-10.18

-8.75

-7.51

-6.92

Net Income Growth

aa.aa

-70.79%

-18.11%

+14.1%

+14.14%

+7.89%

Net Income Margin %

aa.aa

-2,914.23%

-699.91%

-448.03%

-218.28%

-197.72%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-8.62

-10.18

-8.75

-7.51

-6.92

Basic EPS - Continuing Operations

aa.aa

-0.02

-0.01

Basic EPS - Continuing Operations Growth

aa.aa

-2.82%

+8.76%

+35.08%

+26.34%

+15.86%

Diluted EPS - Continuing Operations

aa.aa

-0.02

-0.01

Diluted EPS - Continuing Operations Growth

aa.aa

-2.82%

+8.76%

+35.02%

+26.41%

+15.26%

Basic Weighted Average Shares Outstanding

aa.aa

549.62

711.48

941.42

1,097.2

1,201.15

Diluted Weighted Average Shares Outstanding

aa.aa

549.62

711.48

941.42

1,097.2

1,201.15

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-7.46

-8.53

-8.83

-7.79

-7.6

EBITDA Growth

aa.aa

-95.56%

-14.35%

-3.54%

+11.79%

+2.47%

EBITDA Margin %

aa.aa

-2,522.17%

-586.48%

-452.49%

-226.49%

-217.23%

EBIT

aa.aa

-7.6

-8.63

-8.88

-7.9

-7.72

* In Millions of AUD (except for per share items)

FAQ

What was Arovella Therapeutics’s revenue at year end?

At the end of the last reported fiscal year, Arovella Therapeutics (ALA) recorded total revenue of 3.498 million AUD.

How much revenue did Arovella Therapeutics report in the most recent quarter?

In its most recent quarterly earnings report, Arovella Therapeutics posted revenue of 0.289 million AUD.

What was Arovella Therapeutics’s net income for the year?

For the full year, Arovella Therapeutics reported net income of -6.916 million AUD.

How much net income did Arovella Therapeutics post in the last quarter?

In the most recent quarter, Arovella Therapeutics (ALA) posted net income of -5.038 million AUD.

What was Arovella Therapeutics’s gross profit for the year?

Gross profit for the year was reported at 3.498 million AUD.

How much gross profit did Arovella Therapeutics generate last quarter?

Arovella Therapeutics recorded gross profit of 0.289 million AUD in its latest quarterly report.

What was Arovella Therapeutics’s annual operating income?

For the full year, Arovella Therapeutics (ALA) reported operating income of -7.716 million AUD.

What was Arovella Therapeutics’s operating income last quarter?

Quarterly operating income was -5.422 million AUD.

What was Arovella Therapeutics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -5.364 million AUD.

What was the quarter-over-quarter change in EBITDA for Arovella Therapeutics?

EBITDA changed by -139.965% million AUD compared to the last quarter.

What is Arovella Therapeutics’s most recent net income margin?

Net income margin based on recent financials is -1,741.821% million AUD.

What is Arovella Therapeutics’s most recent EBIT margin?

Arovella Therapeutics reported an EBIT margin of -1,874.736% million AUD based on current figures.

How did Arovella Therapeutics’s revenue change compared to the previous quarter?

Revenue changed by -90.987% million AUD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Arovella Therapeutics?

In the latest quarter, gross profit changed by -90.987% million AUD from the previous quarter.

S&P/TSX

36,553.92

-280.33

-0.76%

S&P/TSX 60

2,144.24

-11.04

-0.51%

US 30

53,496.50

-62.8

-0.12%

US 500

7,696.00

-15.5

-0.20%

S&P 500 VIX

14.43

-0.08

-0.55%

DAX

26,569.99

+202.75

+0.77%

Dollar Index

99.63

-0.030

-0.03%

Market Movers

Name	Last	Chg. %	Vol.
Suncor Energy	91.09	-1.09%	10.53M
RBC	284.17	+0.25%	3.15M
Canadian Natural	68.14	-1.29%	12.70M
Bank of Montreal	239.23	+0.23%	3.41M
Enbridge	69.76	+0.69%	7.22M
Bank of Nova Scotia	128.36	-0.37%	3.89M
Toronto Dominion Bank	168.61	+0.46%	2.24M

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Regenera Insights	0.02	+100.00%	3.00K
Martello Tech	0.0100	+100.00%	17.70K
1933 Industries	0.0100	+100.00%	102.00K
LFNT Resources	0.20	+90.48%	17.50K

Name	Last	Chg. %	Vol.
EnviroMetal Technologies	0.01	-100.00%	1.46K
Global Health Clinics	0.055	-80.00%	500.00
Patriot Gold	0.02	-76.92%	10.02K
Patriot Gold	0.02	-76.92%	10.02K
CardioComm Solutions Inc.	0.0050	-50.00%	1.00K
Ramm Pharma	0.01	-50.00%	1.00K
Molecule Holdings	0.005	-50.00%	20.11K

Trending Stocks

Name	Last	Chg. %	Vol.
Equinox Gold	18.07	-3.06%	3.64M
Toronto Dominion Bank	168.61	+0.46%	2.24M
Keel Infra	4.49	-7.80%	5.67M
Celestica Inc.	415.52	-5.51%	243.83K
TELUS	13.46	-0.59%	5.41M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa A Aaa	34.86	+55.77%	54.30
Aaaaaa	8.78	+49.70%	13.14
A Aaaaa	119.95	+48.13%	177.68
Aaaaaa Aa	7.85	+45.80%	11.45
A Aaaaaa Aaa	29.45	+45.61%	42.88
Aaaaaaa Aaaaaaa Aaaa	5.42	+44.04%	7.81
Aaaaaaaa	103.85	+43.87%	149.41

Name	Last	Upside	Fair Value
Aa A Aaa	34.86	+55.77%	54.30
Aaaaaa	8.78	+49.70%	13.14
A Aaaaa	119.95	+48.13%	177.68
Aaaaaa Aa	7.85	+45.80%	11.45
A Aaaaaa Aaa	29.45	+45.61%	42.88
Aaaaaaa Aaaaaaa Aaaa	5.42	+44.04%	7.81
Aaaaaaaa	103.85	+43.87%	149.41

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Arovella Therapeutics Ltd (ALA)

ALA Income Statement

FAQ

What was Arovella Therapeutics’s revenue at year end?

How much revenue did Arovella Therapeutics report in the most recent quarter?

What was Arovella Therapeutics’s net income for the year?

How much net income did Arovella Therapeutics post in the last quarter?

What was Arovella Therapeutics’s gross profit for the year?

How much gross profit did Arovella Therapeutics generate last quarter?

What was Arovella Therapeutics’s annual operating income?

What was Arovella Therapeutics’s operating income last quarter?

What was Arovella Therapeutics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Arovella Therapeutics?

What is Arovella Therapeutics’s most recent net income margin?

What is Arovella Therapeutics’s most recent EBIT margin?

How did Arovella Therapeutics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Arovella Therapeutics?

Trending Stocks